Hexamethylmelamine: An evaluation of its role in the treatment of ovarian cancer
Authors:
- J.TAylor WhartonJWJ.TAylor Wharton
- Felix RutledgeFRFelix Rutledge
- Julian P. SmithJSJulian P. Smith
- Jay HersonJHJay Herson
- M.PAt HodgeMHM.PAt Hodge
- 1 April 1979
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 133 (7) , 833-844
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Hexamethylmelamine.An evaluation of its role in the therapy of cancerCancer, 1976
- Hexamethylmelamine—A new drug with activity in solid tumorsEuropean Journal of Cancer (1965), 1973
- Classification and Staging of Malignant Tumours in the Female PelvisActa Obstetricia et Gynecologica Scandinavica, 1971
- Prolonged low-dosage administration of hexamethylmelamine (NC 13875)Cancer, 1970
- Phase II study of hexamethylmelamine (NSC 13875)Cancer, 1969
- The clinical pharmacology of hexamethylmelamine: Phase I studyClinical Pharmacology & Therapeutics, 1967
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958